Featured News

On October 27-28th, 2015, Talia Hassid, Celiac Disease Foundation’s Community Coordinator, attended the Digestive Disease National Coalition Public Policy Forum held in Washington, D.C.  The forum gathers representatives from digestive disease organizations…

On November 9, 2015, Celiac Disease Foundation (CDF) sent a letter to Congressman Chairmen and Ranking Members of the House and Senate Subcommittees on Agriculture, Rural Development, Food and Drug…

Celiac Disease Foundation is pleased to announce its pledge of support for the Teal Pumpkin Project™, an international initiative that promotes safety, inclusion, and respect of individuals managing food allergies…

In 2013, Representative Tim Ryan (D-Ohio) introduced legislation that would apply gluten labeling requirements on all medications, both prescription and over-the-counter. We strongly endorsed this legislation when it was first introduced in 2013, but it never made it to a vote. This year, we pledge to re-double our efforts, along with other celiac disease organizations, to get this vital legislation passed and on to the White House for signature.

              This year, the CDF Southern California Chapter has provided education on celiac disease and gluten sensitivity to more than 500 nurses in Southern California through…

CDF is committed to advancing the delivery of personalized health solutions emerging from the rapidly developing fields of genomics and data collection and analysis. We are a lead institutional participant…

Celiac Disease Foundation Chief Executive Officer, Marilyn G. Geller, was recently appointed to sit on the Royal Caribbean Advisory Board on Disabilities. The Advisory Board held its first meeting in May 2015, and was established by the cruise line to improve the travel experience for guests with disabilities

On May 11, 2015, CDF CEO Marilyn G. Geller was proud to represent the celiac community at the public meeting of the U.S. Food and Drug Administration Functional GI Patient-Focused…

On May 11, 2015, the Food and Drug Administration (FDA) will conduct a public meeting on Functional GI Disorders Patient-Focused Drug Development. Celiac Disease Foundation was requested by the FDA to provide commentary about the impact of celiac disease on patients’ daily lives, the types of treatment benefit that matter most to patients, and patients’ perspectives on the adequacy of the available therapies.

CDF CEO, Marilyn Geller, will present the celiac patient voice at the May 11 FDA Patient-Focused Drug Development meeting. Have your voice be heard. Complete the CDF Celiac PFDD Survey now.